Details of the Drug Combinations

General Information of This Drug (ID: DMJSMDL)

Drug Name

Cefiderocol DMJSMDL

Synonyms

Cephalosporin, GSK2696266; S-649266

Indication

Disease Entry	ICD 11	Status	REF
Hospital-acquired pneumonia	CA40.Z	Approved	[1]
Urinary tract infection	GC08	Approved	[1]
Ventilator-associated pneumonia	PK81.0	Approved	[1]
Healthcare-associated pneumonia	CA00-CA40	Phase 3	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Linezolid + Cefiderocol	DC1IN8D	Linezolid	Healthcare-associated Pneumonia (HCAP)	[3]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
2	ClinicalTrials.gov (NCT02714595) Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens (CREDIBLE - CR). U.S. National Institutes of Health.
3	ClinicalTrials.gov (NCT03032380) Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens